G Substrate level significantly depends on flow rate (two-way analysis of variance): p < 0.05. b Different from control (U-test): p < 0.05. , Different from control (U-test): p < 0.01.
Summary:
The effects of emopamil on postischemic en ergy metabolism and electroencephalographic (EEG) re covery were investigated in the isolated rat brain per fused at either constant pressure or, alternatively, at con stant flow rate. Flow rate and perfusion pressure were monitored continuously. The brains were perfused with a fluorocarbon emulsion for 30 min, and after 30 min of ischemia, perfusion was reinstituted for 5, 30, or 60 min. Global cerebral perfusion rate was increased by emo pamil throughout the perfusion period and. accordingly, in brains perfused at a constant tlow rate, perfusion pres sure was reduced by the drug. At constant pressure per fusion, after 5 min after ischemia, cortical levels of cre atine-phosphate, adenosine triphosphate (ATR), glucose, glucose-6-phosphate, and fructose-6-phosphate were higher in emopamil-treated brains than in controls, al though the levels of adenosine diphosphate (ADP ) and adenosine monophosphate (AMP) were reduced. When brains were perfused at constant tlow rate, however, Calcium entry blockers have been shown to exert a protective effect under ischemic conditions in an imal experiments and clinical trials (Gelmers, 1984; Deshpande and Wieloch, 1985; Mohamed et aI. , 1985b; Steen et aI. , 1985) . In recent studies, emo pamil and other calcium entry blockers accelerated the restoration of high-energy phosphates and the decrease of lactate level following ischemia in the isolated perfused rat brain (Weber and Krieglstein, emopamil exhibited no effect on brain energy metabolism in the early reperfusion period. Postischemic restoration of high-energy phosphates proved to depend on the flow rate used. After 30 min of postischemic reperfusion, cor tical levels of lactate were lower in emopamil-treated brains compared to controls at both constant pressure and constant volume perfusion. Postischemic lactate levels were independent of flow rate and were also re duced when emopamil was only present during reperfu sion. The postischemic restoration of cortical EEG ac tivity was improved by the calcium entry blocker. The results suggest that the restoration of high-energy phos phates during the early postischemic recovery can be mainly attributed to the vascular effect of emopamil, whereas the lower lactate levels are caused by a direct action of the calcium entry blocker on brain parenchyma. Key Words: Calcium entry blocker-EEG-Emopamil -Energy metabolism-Isolated perfusion-Rat brain.
1985; Krieglstein and Weber, 1986) . For most of the drugs investigated, this effect was accompanied by an increase in postischemic perfusion rate (Weber, 1985) . However, the mechanism by which the cal cium entry blockers exert their ameliorative action on cerebral energy metabolism has not been shown. The effects of calcium entry blockers on ce rebral vasculature have been comprehensively monitored during recent years (Hoffmeister et aI. , 1979; Harper et aI. , 1981; Kazda et aI. , 1982; Haws et aI. , 1983; Steen et al. , 1983 Steen et al. , , 1984 Mohamed et aI. , 1984) . Apart from vasculature, however, the proposed mechanism of action suggests that these drugs prevent influx of calcium into the neuronal and glial cells, thereby protecting brain tissue from the deleterious calcium overload that occurs in the course of cerebral ischemia and recirculation (Harris et aI. , 198 1; Yanagihara and McCall, 1982; Hossmann et aI. , 1983) . To differentiate between these two possible sites of action, we used the iso lated perfused rat brain preparation, allowing per fusion at either constant pressure or, alternatively, at constant flow rate. An additional aim of the present investigation was to determine whether or not preischemic application of emopamil IS essen tial for its effects on energy metabolism.
MATERIALS AND METHODS

Materials
Emopamil [1, 7 -bis-(phenyl)-3-aza-7 -cyano-8-methyl nonane hydrochloride] was a gift from Knoll (Ludwig shafen, FR. G. ). Enzymes, coenzymes, and substrates were obtained from Boehringer (Mannheim, F.R. G. ). DL Dithiothreitol, HEPES [4-(2-hydroxyethyl)-piperazine-l ethane-sulfonic acid], imidazole, 2-mercaptoethanol, and I-thioglycerol were purchased from Sigma Chemical Co (St. Louis, MO, U. S. A.). All other chemicals were of re agent grade.
Male Sprague-Dawley rats (lWV, Geretsried, FR. G.), weighing 200-230 g, were used. The animals were main tained under controlled environmental conditions (12-h dark/light cycle, 23 ± 1°C, 55 ± 5% relative humidity) and were kept on standard diet (Altromin, Lage, FR. G. ) and tap water ad libitum until starting the experiment.
Perfusion technique
The rat brain was isolated according to Andjus et al. (1967) and was perfused with a fluorocarbon (FC 43) emulsion (Green Cross Corp. , Osaka, Japan), following a technique described in detail by Dirks et al. (1980) . Either perfusion pressure (100 mm Hg) or perfusate flow rate (3, 4, or 5 ml/min) were maintained at a constant level. Bi polar electroencephalograms (EEG) were recorded from the parietal region of each hemisphere (EEG preamplifier BioAC; Hellige, Freiburg, FR. G. ). EEG recordings were analyzed by EEG Interval Spectrum Analysis (EISA) (T6nnies, Freiburg, FR. G. ). Usually, emopamil was added to the perfusion medium at a concentration of I I-lmollL before perfusion was started. After a perfusion period of 30 min, ischemia was induced for 30 min by switching off medium supply. Following ischemia, perfu sion was reinstituted for 5, 30, or 60 min. In one series of experiments, emopamil was added to the perfusion me dium only in the postischemic perfusion period. Metabo lism was stopped by immersing brains into liquid ni trogen, according to Ponten et al. (1973) .
Enzymatic methods
Cerebral cortical tissue was removed from the brain, weighed, and extracted at -20°C, as described by Fol bergrova et al. (1974) . Creatine-phosphate, ATP, ADP, AMP, glucose, pyruvate, and lactate were measured spectrophotometrically according to the procedures de scribed by Bergmeyer (1970) . Glucose-6-phosphate, fruc tose-6-phosphate, and fructose-I,6-bisphosphate were measured fluorimetrically (Lowry and Passonneau, 1972) .
The energy charge of the adenylate pool, EC = ATP + J CPreh Blood Flow Melah, Vol. 7, No, 4, 1987 0.5 ADP/ATP + ADP + AMP, was calculated according to Atkinson (1968) .
Statistics
Usually, values are presented as means ± SD. The data concerning EEG analysis are presented as means ± SEM. For analysis of the flow dependence of postisch emic energy metabolism and of the influence of emopamil on perfusion rate, two-way analysis of variance was used. All other comparisons between controls and emo pamil-treated groups were made using the Mann-Whitney U -test.
RESULTS
Perfusion rate and perfusion pressure
In the isolated rat brain perfused at constant pressure, the drug increased the perfusion rate ( Fig. IA) . In control brains, perfusate flow rate slightly decreased during the preischemic perfusion period. After reinstituting perfusion following the ischemic period, flow rate gradually increased during the first 5 min without reaching preischemic levels. Perfusion rate then remained constant for approximately 20 min postischemia and, subse quently, gradually decreased. Emopamil exerted the most prominent increase in perfusion rate during the early recovery period. When emopamil was present in the perfusate only during postisch emic reperfusion, the drug increased the flow rate to the same degree as in the preischemic treatment group (Fig. IB) . When brains were perfused at con stant flow rate, perfusion pressure was monitored. The change in perfusion pressure inversely paral leled that of perfusate flow rate in the constant pressure perfused brains. Namely, in the pre ischemic and later postischemic period, the perfu sion pressure of emopamil-treated brains was slightly lower than that of controls. During the first 10 min of postischemic reperfusion, the difference was highest, reaching significance level (data not presented).
Brain energy metabolism
In brains perfused at constant pressure, emo pamil accelerated the restoration of high-energy phosphates during the first 5 min of recirculation. Creatine-phosphate and ATP levels were especially higher, whereas ADP and AMP levels were lower in emopamil-treated than in control brains (Fig. 2) . Emopamil caused a faster restitution of the energy charge of the adenylate pool, which at 5 min of postischemic reperfusion, approximated normal values in the drug-treated group (Fig. 2) . The levels of glucose, glucose-6-phosphate, and fructose-6phosphate were also elevated by the calcium entry blocker; the other glycolytic metabolites were not affected ( Table 1) . When brains were perfused at constant flow rate, during the first 5 min of reperfusion, emopamil caused no significant alterations in the levels of high-energy phosphates or glycolytic interme diates, independent of the flow rate used (Table 1) . The restoration of the high-energy phosphates cre atine-phosphate and AT P and of the adenylate en ergy charge, however, significantly depended on the flow rate used (Table 1, Fig. 3 ). This flow de- pendence was observed for AM P and glucose-6phosphate levels as well. At constant pressure and constant flow rate per fusion, cortical lactate levels were lower in emo pamil-treated brains than in controls 30 min after ischemia ( Fig. 4 ). An influence of flow rate on cor tical lactate levels was not demonstrable. Postisch ernie application of the drug also led to a decrease in lactate level after 30 min of reperfusion. In this series, brains were perfused at constant pressure. Except for lactate, after 30 min of reperfusion, Table 2) .
Effects of emopamil on EEG
In the preischemic perfusion period, emopamil induced no change in the EEG pattern as examined by visual criteria and frequency analysis (Fig. 5) . When medium supply to the brain was stopped, EEG activity disappeared within 30-40 s. When perfusion was reinstituted following an ischemic period of 30 min, the first reappearance of EEG ac- tivity in the form of burst firing was observable at about 20-30 min postischemia. The time that elapsed between the end of ischemia and first EEG activity was not influenced by emopamil (Fig. 5) . EEG frequency analysis, however, revealed a ten dency toward higher beta activity throughout sub sequent recovery, reaching significance level at 55 min after the end of ischemia. In this series, brains were perfused at constant pressure.
DISCUSSION
In the isolated rat brain perfused at constant pressure, global cerebral perfusion rate was higher 3.35 ± 1.66 5.50 ± 1.09b 1.75 ± 0.30 2.20 ± 0.07' 0.48 ± 0.14 0.28 ± 0.04' 0.33 ± 0.22 0.07 ± 0.04' 0.25 ± 0.07 0.44 ± 0.13b 0.15 ± 0.08 0.27 ± 0.04b 0.01 ± 0.01 0.03 ± 0.01' 0.21 ± 0.11 0.28 ± 0.09 9.67 ± 1. 66 8.50 ± 1.53 0.10 ± 0.04 0.15 ± 0.04
Values are means ± SD from 5-7 experiments expressed as fLmollg cortical tissue. In the isolated rat brain, after 30 min of perfusion, complete ischemia was induced for 30 min and then brains were reperfused for 5 min. culatory effects of different calcium entry blockers (Toyoda et aI., 1975; Murata et aI., 1982; Haws et aI., 1983; McCalden et al., 1984; Mohamed et al., 1984 Mohamed et al., , 1985a . The most prominent increase in perfusion rate was observed during the initial recovery period fol lowing ischemia. When brains were perfused at constant flow rate, perfusion pressure was lower in emopamil-treated brains, with the difference be tween controls and treated brains also being most pronounced shortly after ischemia. When brains were supplied with emopamil-containing perfusion medium only during the recovery period, the vas cular action of the calcium entry blocker was ob served shortly after reinstituting perfusion. From about 5 min onwards until the end of the experi ment, the drug-treated brains showed higher flow rates than the corresponding controls. These re sults suggest that the calcium entry blocker was readily delivered to brain vasculature within a few minutes and are in accord with observations in dogs that nimodipine increased cerebral blood flow al most immediately following its administration (Milde et al., 1986) .
ENERGY CHRRGE
The isolated peri'used rat brain preparation was used for the investigations concerning postischemic energy metabolism, as this model offers standard ized experimental conditions for the induction of ischemia. Moreover, when the results obtained at constant pressure perfusion are compared to those observed at constant flow perfusion, one can differ entiate between vascular and direct effects on brain parenchyma. However, brains were perfused at 28°C with a fluorocarbon emulsion, thereby not al lowing quantitative comparison to in vivo data. In the experiments employing constant pressure per fusion, emopamil led to a faster restoration of high energy phosphate levels. This result is consistent with earlier findings of improved postischemic brain energy metabolism by calcium entry blockers (Proctor et aI., 1984; Heffez and Passonneau, 1985; Weber and Krieglstein, 1985; Krieglstein and Weber, 1986) . The results are further confirmed by observations that emopamil and nimodipine accel erate the restoration of high-energy phosphates in the artificially ventilated rat following 10 min of ischemia (Bielenberg et aI., 1987) . The increased levels of glucose, glucose-6-phosphate, and fruc tose-6-phosphate are also consistent with previous findings that in gerbils subjected to a 5-min isch emia, nimodipine led to a faster increase in brain glucose content in the recovery period (Heffez and Passonneau, 1985) . In the isolated rat brain prepa ration, a faster postischemic elevation in glucose-6phosphate levels was also demonstrated for the cal- Values (except ratio) are means ± SD from 5-7 experiments expressed as fLmolig cortical tissue. In the isolated rat brain, after 30 min of perfusion. complete ischemia was induced for 30 min and then brains were reperfused for 30 min. Energy charge of the adenylate pool = AT P + 0.5 ADP/ATP + ADP + AMP. cium entry blockers gallopamil, nimodipine, flunar izine, and diltiazem (Krieglstein and Weber, 1986) .
When brains were perfused at constant flow rate, no alterations in cortical high-energy phosphate levels were observed. Emopamil proved to be un able to exert its accelerating effect on the restitu tion of brain energy stores under these perfusion conditions. Conversely, using different flow rates, a close flow dependency of high-energy phosphate restoration could be demonstrated. At constant pressure perfusion, emopamil increased perfusate flow rate by about 1.5 mllmin during the early re perfusion period. Such an increase can readily ac count for the observed metabolic alterations as de lineated by the results obtained with different flow rates. Therefore, emopamil seems to accelerate the postischemic restoration of high-energy phosphates because of its vasodilating properties. The faster degradation of lactate by emopamil treatment is consistent with previous findings of lowered postischemic lactate in the isolated rat brain perfused with gallopamil (Krieglstein and FIG, 5 . Effect of emopamil on beta-wave con tent of the isolated rat brain perfused at con stant pressu reo Parietally recorded EEG activity was analyzed by interval spectrum analysis.
Values are presented as means ± SEM of 6 ex periments. Different from control (U-test): ** p < 0.01. Weber, 1986) . Our results obtained with two dif ferent flow rates suggest that the decrease in lactate levels following the ischemic insult is independent of the rate by which brains are perfused. Therefore, the lower lactate levels in emopamil-treated brains can be interpreted as a direct drug effect on cere bral parenchyma. This result is not surprising, as postischemic lactate disappearance is made up mostly by oxidative degradation. Although there is a saturable lactate carrier in rat brain (Oldendorf, 1972) , its maximal transport capacity is very low (Cremer et aI., 1979) . Therefore, cerebral blood flow is not the limiting factor for brain to blood movements of lactate.
The crucial role of lactacidosis as a cause of cell death is well documented (cf, Siesj6, 1986) . The faster reduction of lactate should cause an im proved pH homeostasis during recovery. In a re cent study, such correction of pH could be demon strated with nimodipine and verapamil in a model of focal ischemia (Hakim, 1986) . The fact that pH changes were not associated with increases in LCBF support the view of a direct action on brain parenchyma.
The results of the influence of calcium entry blockers on brain lactate levels hitherto obtained were based on drug application prior to the isch emic insult. The present data demonstrate that the action on lactate metabolism does not essentially depend on preischemic application. This is consis tent with the proposed mechanism of action, as the calcium sequestered in neuronal tissue is made up mostly by calcium delivered to the brain during re circulation (Yanagihara and McCall, 1982; Hoss mann et aI., 1983; Simon et aI., 1984) . Therefore, if calcium deteriorates mitochondrial function, and hence hampers oxidative lactate degradation, hin drance of calcium entry during its main intracellular accumulation should be beneficial. However, it should be stressed that a reduced calcium accumu lation elicited by calcium entry blockers has not yet been demonstrated (Hossmann et aI., 1983) . The re sult of drug efficacy after postischemic application is also in line with observations that most of the calcium entry blockers hitherto investigated in models of focal or global ischemia proved to be also effective when applied after the ischemic insult (Wiernsperger et aI., 1984; Deshpande and Wie loch, 1985; Steen et aI., 1985; Grotta et aI., 1986) . Unfortunately, the time limitations inherent in the perfusion model impedes the evaluation of final cell death. However, the ameliorative action of emo pamil on postischemic EEG recovery is indicative of an improved functional resuscitation.
The main objection against the conclusions of our study may be the fact that a global parameter like perfusion rate is compared to locally performed determinations of substrate levels. The question arises as to whether in the constant flow series, in tracerebral redistribution of the perfusate delivered to the brain may be produced by the calcium entry blocker. Therefore, some general remarks should be made in support of our conclusions. As postisch emic lactate degradation proved to be independent of flow rate, it is hardly conceivable that redistribu tion phenomena could account for this effect of emopamil. The missing effects after 5 min of reper fusion, however, could be caused by redistribution of perfusate away from cortical tissue and, hence, may mask an additional direct action of emopamil on brain parenchyma. Such an assumption, how ever, is rather unlikely, as in the conscious rat, there was no obvious difference in cortical blood flow increase compared to other structures (Bielen berg et aI., 1986) . Currently performed local cere bral flow rate determinations reveal that after 5 min of reperfusion at constant flow rate, cortical flow rates are not different between control and emo pamil-treated groups (Bielenberg et aI., 1987) .
The implication of improved cerebral circulation during recovery with respect to final resuscitation after an ischemic insult seems to be conflicting. Flunarizine, a calcium entry blocker with a dif ferent pharmacological profile, reduces ischemic neuronal cell death without influencing local cere bral blood flow (Deshpande and Wieloch, 1985) . By contrast, in a study concerning postischemic cal cium sequestration, the investigators concluded that calcium entry blockers exert their protective effects as a result of their actions on cerebral vascu lature (Hossmann et aI., 1985) . Steen et al. (1985) reported on symmetrical cortical lesions in arterial border zones and emphasized the importance of delayed hypoperfusion, which could be corrected partially by calcium entry blockers. On the other hand, some of the brain stem lesions falling outside arterial border zones also responded to nimodipine therapy. This etIect was discussed with respect to direct drug effects in cerebral parenchyma.
In conclusion, our results suggest that the cal cium entry blocker emopamil exerts both a vasodi lating and a direct etIect on brain parenchyma, and it seems likely that both sites of action contribute to the improvements by calcium entry blockers in ce rebrovascular disease.
